These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9749580)

  • 1. Mitochondrial dysfunction in Parkinson's disease.
    Mizuno Y; Yoshino H; Ikebe S; Hattori N; Kobayashi T; Shimoda-Matsubayashi S; Matsumine H; Kondo T
    Ann Neurol; 1998 Sep; 44(3 Suppl 1):S99-109. PubMed ID: 9749580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical and neurogenetic correlates of Parkinson's disease.
    Mizuno Y; Hattori N; Matsumine H
    J Neurochem; 1998 Sep; 71(3):893-902. PubMed ID: 9721714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinone formation as dopaminergic neuron-specific oxidative stress in the pathogenesis of sporadic Parkinson's disease and neurotoxin-induced parkinsonism.
    Asanuma M; Miyazaki I; Diaz-Corrales FJ; Ogawa N
    Acta Med Okayama; 2004 Oct; 58(5):221-33. PubMed ID: 15666991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of Parkinson's disease.
    Schapira AH
    Baillieres Clin Neurol; 1997 Apr; 6(1):15-36. PubMed ID: 9426866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria in the etiology and pathogenesis of Parkinson's disease.
    Schapira AH; Gu M; Taanman JW; Tabrizi SJ; Seaton T; Cleeter M; Cooper JM
    Ann Neurol; 1998 Sep; 44(3 Suppl 1):S89-98. PubMed ID: 9749579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of mitochondria in the etiology and pathogenesis of Parkinson's disease.
    Mizuno Y; Ikebe S; Hattori N; Nakagawa-Hattori Y; Mochizuki H; Tanaka M; Ozawa T
    Biochim Biophys Acta; 1995 May; 1271(1):265-74. PubMed ID: 7599219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial dysfunction and biogenesis in the pathogenesis of Parkinson's disease.
    Lin TK; Liou CW; Chen SD; Chuang YC; Tiao MM; Wang PW; Chen JB; Chuang JH
    Chang Gung Med J; 2009; 32(6):589-99. PubMed ID: 20035637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heredity in Parkinson's disease: new findings.
    Lev N; Melamed E
    Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease--resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2012 Nov; 53(9):1791-806. PubMed ID: 22967820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.
    Büeler H
    Exp Neurol; 2009 Aug; 218(2):235-46. PubMed ID: 19303005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases.
    Gu M; Owen AD; Toffa SE; Cooper JM; Dexter DT; Jenner P; Marsden CD; Schapira AH
    J Neurol Sci; 1998 Jun; 158(1):24-9. PubMed ID: 9667773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson's Disease Research Group.
    Schapira AH; Mann VM; Cooper JM; Krige D; Jenner PJ; Marsden CD
    Ann Neurol; 1992; 32 Suppl():S116-24. PubMed ID: 1510369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.
    Sun F; Kanthasamy A; Anantharam V; Kanthasamy AG
    Pharmacol Ther; 2007 Jun; 114(3):327-44. PubMed ID: 17521740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic effects of dopamine metabolism in Parkinson's disease.
    Hattoria N; Wanga M; Taka H; Fujimura T; Yoritaka A; Kubo S; Mochizuki H
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S35-8. PubMed ID: 19131041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress and genetics in the pathogenesis of Parkinson's disease.
    Zhang Y; Dawson VL; Dawson TM
    Neurobiol Dis; 2000 Aug; 7(4):240-50. PubMed ID: 10964596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial complex I deficiency in Parkinson's disease.
    Schapira AH
    Adv Neurol; 1993; 60():288-91. PubMed ID: 8420145
    [No Abstract]   [Full Text] [Related]  

  • 19. Mitochondrial dysfunctions in Parkinson's disease.
    Gautier CA; Corti O; Brice A
    Rev Neurol (Paris); 2014 May; 170(5):339-43. PubMed ID: 24119854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dysfunction in neurodegenerative disorders.
    Schapira AH
    Biochim Biophys Acta; 1998 Aug; 1366(1-2):225-33. PubMed ID: 9714816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.